Non Invasive Prenatal Testing (NIPT) Market expected to grow at the highest CAGR during the forecast period

According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

Non Invasive Prenatal Testing segmented into :

- By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.

- Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).

- Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.

Request for Sample pages :https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690

Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region

What Drives the Market?

The growth of the global market for Non Invasive Prenatal Testing (NIPT) is primarily influenced by the following factors:

• High Risk of Chromosomal Abnormalities With Increasing Maternal Age

• Growing Preference for Noninvasive Techniques Over Invasive Methods

• Improving Reimbursement Scenario for NIPT

• Programs Focusing on Increasing the Awareness of NIPT

Untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. On the other hand, a dearth of skilled professionals is expected to restrain the growth of this market in the coming years.

Cosmetic Lasers Market : Opportunities and Challenges

 According to the new market research report " Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) - Forecasts to 2021 " , published by MarketsandMarkets™, the global aesthetic/cosmetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94673613

Some of The Major Players In Aesthetic/Cosmetic Lasers Market :

1. Aerolase (U.S.)
2. Alma Lasers, Ltd. (Israel)
3. Cutera, Inc. (U.S.)
4. Cynosure, Inc. (U.S.)
5. El.En. SpA (Italy)
6. Lumenis Ltd. (Israel)
7.Sciton, Inc. (U.S.)
8. SharpLight Technologies (Israel), etc.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=94673613

Aesthetic/Cosmetic Lasers Market segmented into :

+ Based on type, the aesthetic/cosmetic lasers type market is segmented into standalone lasers and multiplatform lasers. In this market, multiplatform lasers formed the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications.

+ Based on application, the aesthetic/cosmetic lasers type market is segmented into vascular lesions, acne & scars, pigmented lesions & tattoos, hair removal, skin rejuvenation, leg veins & varicose veins, and other applications (onychomycosis and gynecological conditions).

+ Based on end user, the aesthetic/cosmetic lasers type market is segmented into hospitals, private clinics, and medical spas.

Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=94673613

Intraoperative Radiation Therapy Market worth $68 million by 2024

The rising incidence of cancer, technological advancements such as the introduction of mobile IORT system, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.

The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by method, in 2019

Based on method, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy. The electron IORT segment is expected to account for the largest share of the intraoperative radiation therapy market in 2019. The large share of this segment can be attributed to its advantages such as better depth dose distribution, low treatment time, and optimal dose homogeneity as compared to HDR-IORT or kV IORT.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083

The other cancers segment, by application, is to register the highest CAGR in the intraoperative radiation therapy market during the forecast period

Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers. The other cancer application segment includes penile cancer, lung cancer, childhood cancer, colorectal cancer, endometrial & cervical cancer, and prostate cancer. This segment is expected to grow at the fastest CAGR owing to growing research activities in new application areas of the IORT market.

North America to dominate the intraoperative radiation therapy market during the forecast period

The intraoperative radiation therapy market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. The North American region is expected to account for the largest share of the intraoperative radiation therapy market in 2019. The growth in this market is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of IORT products owing to the increasing incidence of cancer.

The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), IntraOp Medical Corporation (US), Ariane Medical Systems, Ltd. (UK), Sordina IORT Technologies S.p.A. (Italy), Sensus Healthcare, Inc. (US), Elekta AB (Sweden), Varian Medical Systems, Inc. (US), GMV Innovating Solutions (Spain), and Eckert & Ziegler Group (Germany).

Read More@
https://www.marketsandmarkets.com/PressReleases/intraoperative-radiation-therapy.asp

Digital Therapeutics Market Industry Analysis, Size, Share, Growth, Trends and Forecast

 According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

Download PDF Brochure :
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724

The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.

Browse and in-depth TOC on "Digital Therapeutics Market"
148 - Tables
186 - Pages
36 - Figures

Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:
https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

The digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms. Each segment has different market players and market leaders. For instance, the prediabetes market was led by Omada in 2015. Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease. Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program. The company has succeeded in securing heavy investments which it channelizes into the development, enhancement, and commercialization of its product.

The key strategies followed by most companies in the digital therapeutics market are agreements, collaborations, and partnerships; investments; and new product launches. Among all growth strategies adopted by market players, agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Some leading players adopting these strategies include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), and Mango Health Inc. (U.S.).

Make an Inquiry Prior To Purchase this research study at: https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html

The growing applications of synthetic biology is a major driver for the growth of market.

Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

Some of The Major Players In Synthetic Biology Market:
1. Thermo Fisher (US)
2. Novozymes (Denmark)
3. Merck KGaA (Germany)
4. Intrexon (US)
5. Agilent Technologies (US)
5. Amyris (US)
6. GenScript (US)
7. Ginkgo Bioworks (US)
8. DNA Technologies (US)

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

* Synthetic biology can broadly be described as the engineering and design of new biological parts and functions such as artificial biological pathways and organisms, which can further be used to produce end-products such as biofuels, biosensors, etc. Synthetic biology also includes the redesign of natural biological systems.

* The global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes.

Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889

Synthetic Biology Market worth $8.84 Billion by 2022

According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.

Early buyers will receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889

In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.

Browse and in-depth TOC on “Synthetic Biology Market”
162 - Tables
32 - Figures
214 - Pages

Get Bundle Reports @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html

By application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) applications. The biofuel and renewable energy segment is estimated to grow at the highest CAGR during the forecast period. This high growth rate is attributed to the rising popularity of biofuels and the advantages of using genetically engineered organisms for the synthetic production of biofuels.

Key players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US). These players are increasingly collaborating, and partnering with companies to offer their synthetic oligonucleotides and to develop synthetic organisms.

Oncology Nutrition Market by Cancer Type - Global Forecast to 2023

According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period. Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.

Get free Sample Report @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.

Browse and in-depth TOC on " Oncology Nutrition Market "
11 – Tables
23 - Figures
92 - Pages

Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967

Factors such as the shift from parenteral to enteral nutrition along with the increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the oncology nutrition market.

Furthermore, the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of excipients. However, the complications associated with tube feeding and limited reimbursements represent a significant challenge to the market growth. The oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from an estimated USD 1.46 Billion in 2018, at a CAGR of 8.7% during the forecast period.

Get 10% customization on report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=166703967